肝癌复发已成为肝癌病人接受治愈性治疗后影响长期存活的主要因素。68%~96%的肝癌复发属肝内复发。肝癌复发大大缩短病人存活期，是术后死亡的主要原因。复发原因可以分为肝内原发肿瘤的复发（真正的复发）或新的癌灶的出现。复发性肝癌的治疗原则与治疗首次原发性肝癌的原则基本相同。选定合适的病人，行积极的、多学科会诊治疗，可延长病人的存活期并改善病人的生活质量。然而，复发性肝癌的治疗仍是一个有限的研究领域。

Reasonable option of management approaches for recurrent liver cancer        LAU Wan-yee, LAI Chun-hung, LAU Hiu-yan. Faculty of Medicine, the Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Corresponding author：LAU Wan-yee, E-mail：josephlau@cuhk.edu.hk
Abstract    Recurrence of liver cancer has become the main factor influencing long-term survival of patients performed curative therapy, which is the main reason for postoperative death because of the shortening of survival. Recurrent disease can result from intrahepatic dissemination of a primary tumor (true recurrence) or from de novo development of a new tumor. The principle that determines the choice of therapy for recurrent  liver cancer is the same as that for primary tumor. An aggressive approach to recurrent liver cancer in selected patients is recommended, and a multi-modality approach can prolong survival and improve quality of life of patients. However, the best treatment of recurrent liver cancer remains investigated poorly.